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Introduction:  Pedal edema is considered to be a common and annoying adverse effect of calcium channel blockers (CCBs). It has been thought 
to result from paralysis of the precapillary sphincter causing intracapillary hypertension.
Methods: A MEDLINE and COCHRANE search was done from 1960 to September 2009 for randomized controlled trials (RCTs) showing the 
incidence of edema with CCBs in patients with hypertension. Studies with the sample size >100 were chosen for our analysis. Separate analysis was 
done for the patient withdrawal from CCBs due to pedal edema.
Results: 111 studies with the total patient population of 79,631 (mean age of 57± 7, 55% males) were included in the analysis. 6551 out of 
37,106 patients (17.7%) had pedal edema on CCBs compared to 1986 of 34,654 patients (5.7%) on control/placebo, p<0.00001. Similarly, the 
patient withdrawal rate due to edema was higher in patients on CCBs (4.2%) compared to control/placebo (0.2%), p<0.00001. Both the incidence 
of edema and patient withdrawal rate due to edema increased with the duration of therapy with CCBs. Edema with high dose CCBs (defined as more 
than half the usual maximal dose) (19.5 per 100 person-years) was 2.9 times higher than with low dose CCBs (6.8 per 100 person-years).
Conclusion: The incidence of pedal edema progressively increases with duration of CCB therapy up to 6 months. 
Over the long term, more than 25% of patients with pedal edema discontinued CCBs because of this adverse effect.
